Literature DB >> 6510486

Effect of 5'-methylthioadenosine (a naturally occurring nucleoside) on murine hematopoiesis.

R W Wolford, M K Riscoe, L Johnson, A J Ferro, J H Fitchen.   

Abstract

5'-Methylthioadenosine (MTA), a naturally occurring nucleoside, inhibited in vitro colony formation by murine erythroid (CFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells in a dose-dependent fashion with maximal inhibition at concentrations of 2 X 10(-3) M and 1 X 10(-4) M, respectively. The inhibitory effect was reversible after up to 8 h of exposure to MTA but was irreversible after 24 h. MTA also inhibited hematopoietic progenitors in vivo. In mice given daily intraperitoneal injections of MTA for 28 days, CFU-GM were maximally reduced on day 14 to 51% of control. CFU-GM returned toward control levels by day 28 despite the continued administration of MTA. Hematocrit and leukocyte count were not reduced until day 28 and then only to 90% and 70% of control, respectively. MTA reached peak plasma levels of 2.8 X 10(-5) M 5 min after a single intraperitoneal injection of 75 mg/kg and was almost completely cleared by 60 min. These findings indicate that MTA produces reversible inhibition of murine hematopoietic progenitors both in vitro and in vivo. Despite the inhibitory effect on progenitors there is little effect on peripheral blood counts, which suggests that MTA inhibits hematopoietic proliferation without affecting hematopoietic differentiation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6510486

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  6 in total

1.  Increasing the therapeutic index of 5-fluorouracil and 6-thioguanine by targeting loss of MTAP in tumor cells.

Authors:  Baiqing Tang; Joseph R Testa; Warren D Kruger
Journal:  Cancer Biol Ther       Date:  2012-07-24       Impact factor: 4.742

Review 2.  Targeting tumors that lack methylthioadenosine phosphorylase (MTAP) activity: current strategies.

Authors:  Joseph R Bertino; William R Waud; William B Parker; Martin Lubin
Journal:  Cancer Biol Ther       Date:  2011-04-01       Impact factor: 4.742

3.  Methylthioadenosine phosphorylase in human breast cancer.

Authors:  R Smaaland; J S Schanche; S Kvinnsland; J Høstmark; P M Ueland
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

4.  Lupus autoimmunity altered by cellular methylation metabolism.

Authors:  Mei-Ling Yang; Alaric J P Gee; Renelle J Gee; Cecilia I Zurita-Lopez; Shilpi Khare; Steven G Clarke; Mark J Mamula
Journal:  Autoimmunity       Date:  2012-11-01       Impact factor: 2.815

5.  Methylthioadenosine (MTA) inhibits melanoma cell proliferation and in vivo tumor growth.

Authors:  Pedro Andreu-Pérez; Javier Hernandez-Losa; Teresa Moliné; Rosa Gil; Judit Grueso; Anna Pujol; Javier Cortés; Matias A Avila; Juan A Recio
Journal:  BMC Cancer       Date:  2010-06-08       Impact factor: 4.430

6.  Selective killing of tumors deficient in methylthioadenosine phosphorylase: a novel strategy.

Authors:  Martin Lubin; Adam Lubin
Journal:  PLoS One       Date:  2009-05-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.